Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?
Olema Pharmaceuticals Ownership Summary
Olema Pharmaceuticals is owned by 102.44% institutional investors, 3.67% insiders. Bvf inc/il is the largest institutional shareholder, holding 16.23% of OLMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in Olema Pharmaceuticals shares.
OLMA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Olema Pharmaceuticals | 102.44% | 3.67% | -6.11% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 9.14M | 16.23% | $98.85M |
| Paradigm biocapital advisors lp | 7.90M | 14.04% | $85.52M |
| Deep track capital, lp | 4.00M | 7.11% | $43.28M |
| Blackrock | 4.00M | 7.11% | $43.27M |
| Point72 asset management | 3.21M | 5.71% | $34.75M |
| Logos global management lp | 3.21M | 5.70% | $34.72M |
| Vanguard group | 2.74M | 4.87% | $29.68M |
| Bioimpact capital | 2.65M | 4.72% | $28.73M |
| State street | 1.95M | 3.46% | $21.08M |
| Vivo capital | 1.87M | 3.33% | $20.27M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bioimpact capital | 2.65M | 4.46% | $28.73M |
| Paradigm biocapital advisors lp | 7.90M | 3.27% | $85.52M |
| Logos global management lp | 3.21M | 2.79% | $34.72M |
| Bvf inc/il | 9.14M | 2.77% | $98.85M |
| Vivo capital | 1.87M | 1.87% | $20.27M |
| Ghost tree capital | 550.00K | 1.86% | $5.95M |
| Great point partners | 796.88K | 1.65% | $8.62M |
| Silverarc capital management | 546.86K | 1.40% | $5.92M |
| Deep track capital, lp | 4.00M | 1.29% | $43.28M |
| Highvista strategies | 247.88K | 0.98% | $2.68M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 3.21M | 0.09% | 3.21M |
| Great point partners | 796.88K | 1.65% | 796.88K |
| Blackrock | 4.00M | 0.00% | 782.96K |
| Deep track capital, lp | 4.00M | 1.29% | 774.58K |
| Candriam s.c.a. | 1.06M | 0.07% | 705.65K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.95M | 0.00% | -1.23M |
| Logos global management lp | 3.21M | 2.79% | -1.18M |
| Janus henderson group | 56.00K | 0.00% | -1.17M |
| Polar capital | - | - | -1.00M |
| Braidwell lp | - | - | -704.34K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 3.21M | 0.09% | 3.21M | $34.75M |
| Great point partners | 796.88K | 1.65% | 796.88K | $8.62M |
| Boxer capital | 650.00K | 0.37% | 650.00K | $7.03M |
| Schroder investment management group | 159.74K | 0.00% | 159.74K | $1.73M |
| Trexquant investment lp | 114.64K | 0.02% | 114.64K | $1.24M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Abich financial wealth management | -10.00 |
| Us bancorp \de\ | -157.00 |
| Comerica bank | -354.00 |
| Pacer advisors | -580.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 135 | 4.65% | 58,661,342 | 1.34% | 102 | 0.97% | 68 | -16.05% | 41 | 28.13% |
| Jun 30, 2024 | 129 | - | 57,887,400 | 3.20% | 102 | 1.01% | 81 | 15.71% | 32 | -3.03% |
| Mar 31, 2024 | 129 | 6.61% | 56,092,366 | 8.80% | 100 | 0.78% | 70 | -5.41% | 33 | 50.00% |
| Dec 31, 2023 | 121 | 15.24% | 51,555,296 | 9.00% | 113 | 1.03% | 74 | 37.04% | 22 | -26.67% |
| Sep 30, 2023 | 105 | 16.67% | 47,296,313 | 29.98% | 105 | 1.32% | 54 | -6.90% | 30 | 42.86% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.63M | 2.85% | 143.43K |
| iShares Russell 2000 ETF | 1.02M | 1.78% | -2.30K |
| SPDR® S&P Biotech ETF | 997.79K | 1.74% | 11.05K |
| Belfius Equities Cure C Cap | 860.55K | 1.50% | 157.55K |
| Candriam Global Equities Oncology | 860.55K | 1.50% | 187.55K |
| Candriam Eqs L Biotech C USD Cap | 646.16K | 1.13% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 587.90K | 1.03% | -1.97K |
| Pictet-Biotech P USD | 554.05K | 0.97% | 554.05K |
| Fidelity Small Cap Index | 408.65K | 0.71% | -10.56K |
| Polar Capital Biotech S Inc | 363.82K | 0.64% | -636.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 13, 2024 | Graham G. Walmsley | - | Buy | $4.73M |
| Dec 13, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 10, 2024 | Harmon Cyrus | - | Sell | $77.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | 17 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 8 |
| 2024 Q1 | - | 5 |
| 2023 Q4 | 4 | 23 |
OLMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools